Retinitis pigmentosa gene therapy — the viral vector-mediated delivery of functional copies of mutated genes responsible for inherited photoreceptor degeneration — represents the most transformative development in retinitis pigmentosa treatment, with the Retinitis Pigmentosa Treatment Market reflecting gene therapy as the market-defining treatment innovation.
Luxturna (voretigene...